LUAD patients harboring STK11 mutations were shown to have low densities of CD8+ TILs in tumor beds, in contrast to STK11 wildtype LUAD patients who displayed high levels of CD4+ and CD8+ T cells (211). Here, STK11 is linked to neoplasm.